Back to All NewsSinclair Announces Acquisition of Viora
Posted By American Med Spa Association, Tuesday, July 12, 2022
Share
Sinclair announces its acquisition of Viora, boosting its energy-based devices (EBD) portfolio and gaining direct commercial base in the United States.
Sinclair, a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces the acquisition of the group of companies that form the Viora group (“Viora” or the “Company”).
Founded in 2005 by Josef Luzon and Danny Erez and based in New York, NY, Viora’s advanced, non-invasive products include the most advanced devices incorporating laser, IPL and proprietary RF technologies.
Viora has solutions that are suitable for all aesthetic practitioners, dermatologists, cosmetic and plastic surgeons, general practitioners and dentists as well as cosmeticians and medical spa owners. Viora products are used around the world by over ten thousand customers. The Company has direct commercial operations in the US and in addition manages a global distribution network of over 60 countries. Viora’s leading brands include V-series multi technology platforms, Reaction, Infusion, and Pristine.
Viora’s non-invasive and minimally invasive aesthetic devices address the most sought-after treatments in the aesthetic market including among others: skin tightening, body contouring, cellulite and circumferential reduction, scar and stretch mark revision, acne clearance, hair reduction, skin rejuvenation, wrinkle reduction.
Miguel Pardos, CEO of Sinclair EBD division commented, “We are delighted that we have brought Viora into the Sinclair family, which expands not only Cocoon’s product offering, via a variety of technologies, but also our direct commercial presence into the United States. Viora’s dedication to clinical and technical training as well as practice development has contributed significantly to its business growth and reputation and fits perfectly with Sinclair’s culture.”
The CEO of Viora, Eliran Almog stated “This acquisition is a strong recognition of Viora’s success in the aesthetic medical device market in the US, and its unique concept enables customers full flexibility and control on their technology growth, together with a one-of-a-kind practice development support. These exceptional assets are a result of the many years of hard work of our skillful and dedicated employees all over the world. We are confident that the values and culture Viora shares with Cocoon, will create a new powerhouse in the aesthetic industry.”
Read more at Sinclair >>
Sinclair, a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces the acquisition of the group of companies that form the Viora group (“Viora” or the “Company”).
Founded in 2005 by Josef Luzon and Danny Erez and based in New York, NY, Viora’s advanced, non-invasive products include the most advanced devices incorporating laser, IPL and proprietary RF technologies.
Viora has solutions that are suitable for all aesthetic practitioners, dermatologists, cosmetic and plastic surgeons, general practitioners and dentists as well as cosmeticians and medical spa owners. Viora products are used around the world by over ten thousand customers. The Company has direct commercial operations in the US and in addition manages a global distribution network of over 60 countries. Viora’s leading brands include V-series multi technology platforms, Reaction, Infusion, and Pristine.
Viora’s non-invasive and minimally invasive aesthetic devices address the most sought-after treatments in the aesthetic market including among others: skin tightening, body contouring, cellulite and circumferential reduction, scar and stretch mark revision, acne clearance, hair reduction, skin rejuvenation, wrinkle reduction.
Miguel Pardos, CEO of Sinclair EBD division commented, “We are delighted that we have brought Viora into the Sinclair family, which expands not only Cocoon’s product offering, via a variety of technologies, but also our direct commercial presence into the United States. Viora’s dedication to clinical and technical training as well as practice development has contributed significantly to its business growth and reputation and fits perfectly with Sinclair’s culture.”
The CEO of Viora, Eliran Almog stated “This acquisition is a strong recognition of Viora’s success in the aesthetic medical device market in the US, and its unique concept enables customers full flexibility and control on their technology growth, together with a one-of-a-kind practice development support. These exceptional assets are a result of the many years of hard work of our skillful and dedicated employees all over the world. We are confident that the values and culture Viora shares with Cocoon, will create a new powerhouse in the aesthetic industry.”
Read more at Sinclair >>
